Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4321 to 4335 of 7691 results

  1. Allogeneic stem cell transplantation:- What is the effectiveness of combined autologous–allogeneic stem cell transplantation compared with autologous stem cell transplantation, plus consolidation and maintenance treatment in chemosensitive patients at first response or first relapse?

    Recommendation ID NG35/4 Question Allogeneic stem cell transplantation:- What is the effectiveness of combined autologous–allogeneic stem

    Research recommendation
    Published
    5 April 2016

  2. Are comprehensive early interventions that combine multiple elements and are delivered by parents and teachers (for example, the Learning Experiences – an Alternative Program for Preschoolers and their Parents [LEAP] model) effective in managing the core features of autism and coexisting difficulties (such as adaptive behaviour and developmental skills) in pre‑school children?

    Recommendation ID CG170/4 Question Are comprehensive early interventions that combine multiple elements and are delivered by parents and

    Research recommendation
    Published
    10 August 2021

  3. Are environmental interventions clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?

    Recommendation ID CG120/7 Question Are environmental interventions clinically and cost effective when compared with standard care for people

    Research recommendation
    Published
    9 June 2015

  4. Are interventions designed to improve the quality of the mother–baby relationship in the first year after childbirth effective in women with a diagnosed mental health problem?

    Recommendation ID CG192/3 Question Are interventions designed to improve the quality of the mother–baby relationship in the first year

    Research recommendation
    Published
    9 June 2015

  5. Are interventions for psychosis or substance misuse clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?

    Recommendation ID CG120/5 Question Are interventions for psychosis or substance misuse clinically and cost effective when compared with

    Research recommendation
    Published
    9 June 2015

  6. Are interventions for psychosis or substance misuse clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?

    Recommendation ID CG120/8 Question Are interventions for psychosis or substance misuse clinically and cost effective when compared with

    Research recommendation
    Published
    9 June 2015

  7. E-cigarettes for harm reduction: Are nicotine-containing e‑cigarettes effective and safe for harm reduction when used alongside tobacco products to cut down on smoking (dual-use approach)?

    Recommendation ID NG209/06 Question E-cigarettes for harm reduction: Are nicotine-containing e‑cigarettes effective and safe for harm reduction

    Research recommendation
    Published
    17 December 2021

  8. Nicotine replacement therapy and e-cigarettes and pregnancy: Are nicotine replacement therapy or nicotine-containing e-cigarettes effective to help women stop smoking in pregnancy (and at what dose)?

    Recommendation ID NG209/02 Question Nicotine replacement therapy and e-cigarettes and pregnancy: Are nicotine replacement therapy or...

    Research recommendation
    Published
    17 December 2021

  9. Opt-out strategies for front-line health and social care staff:- Are opt-out strategies effective and cost effective at increasing uptake of flu vaccination among front-line health and social care staff?

    Recommendation ID NG103/4 Question Opt-out strategies for front-line health and social care staff:- Are opt-out strategies effective and

    Research recommendation
    Published
    12 December 2018

  10. Relapse prevention: Are NRT or nicotine-containing e‑cigarettes effective for preventing relapse after a successful quit attempt?

    Recommendation ID NG209/11 Question Relapse prevention: Are NRT or nicotine-containing e‑cigarettes effective for preventing relapse after

    Research recommendation
    Published
    17 December 2021

  11. Second-generation endometrial ablation for HMB associated with myometrial pathology:- Are outcomes after second-generation endometrial ablation for women with HMB associated with myometrial pathology (adenomyosis and/or uterine fibroids) equivalent to those for women without myometrial pathology?

    Recommendation ID NG88/5 Question Second-generation endometrial ablation for HMB associated with myometrial pathology:- Are outcomes after

    Research recommendation
    Published
    14 November 2018

  12. Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received radiotherapy (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    Recommendation ID NG162/1 Question Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are

    Research recommendation
    Published
    21 October 2021

  13. Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received systemic anticancer treatment (SACT) (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    Recommendation ID NG161/1 Question Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and

    Research recommendation
    Published
    21 October 2021

  14. Duration of risk of radiotherapy in people with cancer and COVID-19: Are people who have had radiotherapy recently (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of poor outcomes from COVID-19 compared with those who had radiotherapy less recently?

    Recommendation ID NG162/2 Question Duration of risk of radiotherapy in people with cancer and COVID-19: Are people who have had radiotherapy

    Research recommendation
    Published
    21 October 2021

  15. Duration of risk of systemic anticancer treatment in people with cancer and COVID-19: Are people who have had SACT recently (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of poor outcomes from COVID-19 compared with those who had SACT less recently?

    Recommendation ID NG161/2 Question Duration of risk of systemic anticancer treatment in people with cancer and COVID-19: Are people who

    Research recommendation
    Published
    21 October 2021